Bárbara Romagnoli

1.4k total citations
28 papers, 1.0k citations indexed

About

Bárbara Romagnoli is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Bárbara Romagnoli has authored 28 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 11 papers in Molecular Biology and 8 papers in Hematology. Recurrent topics in Bárbara Romagnoli's work include Chemokine receptors and signaling (12 papers), Chemical Synthesis and Analysis (5 papers) and Dendrimers and Hyperbranched Polymers (4 papers). Bárbara Romagnoli is often cited by papers focused on Chemokine receptors and signaling (12 papers), Chemical Synthesis and Analysis (5 papers) and Dendrimers and Hyperbranched Polymers (4 papers). Bárbara Romagnoli collaborates with scholars based in United States, United Kingdom and Spain. Bárbara Romagnoli's co-authors include Wayne Hayes, Anthony P. Reszka, Stephen Neidle, Lloyd R. Kèlland, W. David Wilson, Martin L. Read, Farial A. Tanious, Robert A. Rastall, Helen M. I. Osborn and Garry J. Douglas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Bárbara Romagnoli

28 papers receiving 1.0k citations

Peers

Bárbara Romagnoli
Karolyn A. Oetjen United States
Jonathan D. Ashley United States
James L. LaBelle United States
Milan Reiniš Czechia
Kazunori Toma Japan
Florian Reichart Germany
Yasuo Komatsu Japan
Eric A. Forssen United States
Daniel Pulido Spain
Karolyn A. Oetjen United States
Bárbara Romagnoli
Citations per year, relative to Bárbara Romagnoli Bárbara Romagnoli (= 1×) peers Karolyn A. Oetjen

Countries citing papers authored by Bárbara Romagnoli

Since Specialization
Citations

This map shows the geographic impact of Bárbara Romagnoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bárbara Romagnoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bárbara Romagnoli more than expected).

Fields of papers citing papers by Bárbara Romagnoli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bárbara Romagnoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bárbara Romagnoli. The network helps show where Bárbara Romagnoli may publish in the future.

Co-authorship network of co-authors of Bárbara Romagnoli

This figure shows the co-authorship network connecting the top 25 collaborators of Bárbara Romagnoli. A scholar is included among the top collaborators of Bárbara Romagnoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bárbara Romagnoli. Bárbara Romagnoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gonçales, Relber Aguiar, Elton J. R. Vasconcelos, Thaila Fernanda dos Reis, et al.. (2021). In Silico Identification of Glycosylphosphatidylinositol-Anchored Proteins in Paracoccidioides Spp.. Future Microbiology. 16(8). 589–606. 1 indexed citations
2.
Barlési, Fabrice, Martijn P. Lolkema, Kristoffer Staal Rohrberg, et al.. (2020). 291 Phase Ib study of selicrelumab (CD40 agonist) in combination with atezolizumab (anti-PD-L1) in patients with advanced solid tumors. Regular and Young Investigator Award Abstracts. A178.1–A178. 9 indexed citations
3.
4.
Kaufman, Peter A., Sònia Pernas, Miguel Martín, et al.. (2018). Balixafortide (a CXCR4 antagonist) plus eribulin in HER2-negative metastatic breast cancer (MBC): A Phase I open-label trial. European Journal of Cancer. 92. S117–S118. 2 indexed citations
5.
Karpova, Darja, Susanne Bräuninger, Eliza Wiercinska, et al.. (2017). Mobilization of hematopoietic stem cells with the novel CXCR4 antagonist POL6326 (balixafortide) in healthy volunteers—results of a dose escalation trial. Journal of Translational Medicine. 15(1). 2–2. 36 indexed citations
6.
Gagner, Jean‐Pierre, Yasmeen Sarfraz, Valerio Ortenzi, et al.. (2017). Multifaceted C-X-C Chemokine Receptor 4 (CXCR4) Inhibition Interferes with Anti–Vascular Endothelial Growth Factor Therapy–Induced Glioma Dissemination. American Journal Of Pathology. 187(9). 2080–2094. 34 indexed citations
7.
Xiang, Jingyu, Michelle A. Hurchla, Francesca Fontana, et al.. (2015). CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer. Molecular Cancer Therapeutics. 14(11). 2473–2485. 49 indexed citations
8.
Sison, Edward Allan R., Daniel Magoon, Li Li, et al.. (2015). POL5551, a novel and potent CXCR4 antagonist, enhances sensitivity to chemotherapy in pediatric ALL. Oncotarget. 6(31). 30902–30918. 29 indexed citations
9.
Xiang, Jingyu, Michelle A. Hurchla, Gary D. Luker, et al.. (2014). Abstract 1114: Combination of a novel CXCR4 antagonist with chemotherapy reduces breast cancer bone metastatic tumor burden. Cancer Research. 74(19_Supplement). 1114–1114. 1 indexed citations
10.
Sison, Edward Allan R., Daniel Magoon, Li Li, et al.. (2014). POL5551, a Novel and Potent CXCR4 Antagonist, Enhances Sensitivity to Chemotherapy in an in Vivo Model of High-Risk (HR) Pediatric Acute Lymphoblastic Leukemia (ALL). Blood. 124(21). 3707–3707. 1 indexed citations
11.
Barone, Amy, Rajarshi Sengupta, Nicole M. Warrington, et al.. (2014). Combined VEGF and CXCR4 antagonism targets the GBM stem cell population and synergistically improves survival in an intracranial mouse model of glioblastoma. Oncotarget. 5(20). 9811–9822. 35 indexed citations
12.
Karpova, Darja, Gabriele Spohn, Eliza Wiercinska, et al.. (2013). The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor. Leukemia. 27(12). 2322–2331. 38 indexed citations
13.
Azab, Abdel Kareem, Feda Azab, Phong Quang, et al.. (2011). Dissecting the role of CXCR7 in Cell Trafficking of Endothelial-Cells and Endothelial-Progenitor-Cells in Multiple Myeloma,. Blood. 118(21). 3934–3934. 1 indexed citations
14.
Moncunill, Gemma, Mercedes Armand‐Ugón, Imma Clotet‐Codina, et al.. (2008). Anti-HIV Activity and Resistance Profile of the CXC Chemokine Receptor 4 Antagonist POL3026. Molecular Pharmacology. 73(4). 1264–1273. 44 indexed citations
15.
Robinson, John A., Kerstin Moehle, Thomas Klimkait, et al.. (2007). Discovery of Highly Potent and Selective CXCR4 Inhibitors Using Protein Epitope Mimetics (PEM) Technology. CHIMIA International Journal for Chemistry. 61(4). 147–147. 2 indexed citations
16.
DeMarco, Steven J., Kerstin Moehle, Reshmi Mukherjee, et al.. (2006). Discovery of novel, highly potent and selective β-hairpin mimetic CXCR4 inhibitors with excellent anti-HIV activity and pharmacokinetic profiles. Bioorganic & Medicinal Chemistry. 14(24). 8396–8404. 65 indexed citations
17.
Reszka, Anthony P., Shozeb Haider, Bárbara Romagnoli, et al.. (2004). Evaluation of by disubstituted acridone derivatives as telomerase inhibitors: the importance of G-quadruplex binding. Bioorganic & Medicinal Chemistry Letters. 14(23). 5845–5849. 67 indexed citations
18.
Romagnoli, Bárbara, et al.. (2004). Chiral Poly(aromatic amide ester) Dendrimers Bearing an Amino Acid Derived C3‐Symmetric Core − Synthesis and Properties. European Journal of Organic Chemistry. 2004(20). 4148–4157. 8 indexed citations
19.
Hayes, Wayne, et al.. (2003). One-pot synthesis of multivalent arrays of mannose mono- and disaccharides. Tetrahedron. 59(40). 7983–7996. 77 indexed citations
20.
Romagnoli, Bárbara, Laurence M. Harwood, & Wayne Hayes. (2003). Synthesis of a novel class of chiral polyaromatic amide dendrimers bearing an amino acid derived C3-symmetric core. Tetrahedron Letters. 44(1). 37–40. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karolyn A. Oetjen Breakdown of academic impact, for papers by Jonathan D. Ashley Breakdown of academic impact, for papers by James L. LaBelle Breakdown of academic impact, for papers by Milan Reiniš Breakdown of academic impact, for papers by Kazunori Toma Breakdown of academic impact, for papers by Florian Reichart Breakdown of academic impact, for papers by Yasuo Komatsu Breakdown of academic impact, for papers by Eric A. Forssen Breakdown of academic impact, for papers by Daniel Pulido
Rankless by CCL
2026